Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SillaJen Inc (215600 KS)
Watchlist
52
Analysis
Health Care
•
South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
27 Apr 2025 00:30
APAC Healthcare Weekly (April 27)- Sillajen, Akeso, Innovent Biologics, CSL, Daiichi Sankyo, Lupin
SillaJen got FDA nod for clinical trial indication expansion. FDA approves Akeso’s first drug. Innovent’s cancer drug was approved in China....
Tina Banerjee
Follow
520 Views
Share
bullish
•
Sunic System Ltd.
•
21 Nov 2024 10:02
KOSDAQ150 Index Rebalance: 8 Changes a Side; Fadu Appears to Be a 4 Letter Word
There are 8 changes for the KOSDAQ150 in Dec. Most of the adds are in line but there are of surprises too. Fadu has been ignored for yet another...
Brian Freitas
Follow
439 Views
Share
bearish
•
SillaJen Inc
•
25 Mar 2024 11:40
SillaJen Rights Offering Worth 34% of Outstanding Shares
On 22 March, SillaJen announced that it will conduct a rights offering worth about 129 billion. The rights offering size is 34.5 million shares,...
Douglas Kim
Follow
413 Views
Share
bullish
•
KG Mobility
•
10 May 2023 19:28
Overlooked Aspects of KG Mobility's Passive Flow Trading Opportunities: KOSPI 200 & KRX Auto
In this post, I will explore the overlooked passive flow trading opportunities offered by KG Mobility. Specifically, I will focus on trading...
Sanghyun Park
Follow
410 Views
Share
bearish
•
Cross Asset Strategy
•
31 Jan 2023 11:19
End of Mandatory Lock-Up Periods for 52 Companies in Korea in February 2023
We discuss end of the mandatory lock-up periods for 52 stocks in Korea in February 2023, among which 3 are in KOSPI and 49 are in KOSDAQ.
Douglas Kim
Follow
336 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x